Acute lymphoblastic leukemia is characterized by the occurrence of meningeal relapse in 50 % of cases within one year. Recent studies have shown that craniospinal irradiation or cranial irradiation and intrathecal methotrexate are effective in preventing CNS relapse and prolonging survival in this condition.
slightly more distally but does not reach the junction with the sensory root.
Infiltration of the cerebral parenchyma is rare and in my experience is confined to lymphosarcoma, if primary reticulosis of the brain (microgliomatosis) is excluded. It may occur in conjunction with meningeal infiltration or independently. It may be either perivascular or diffuse even in the same case (Fig 3) . It involves various parts of the brain at random: cortex, white matter, basal ganglia, brain stem (Fig 4) and cerebellum.
Infiltration of peripheral nerves is also rare, occurs in lymphosarcoma (Henson & Urich 1970) and has been reported in other lymphomas (Barron et al. 1960) . The peripheral nerves are infiltrated over long stretches in a random fashion. By contrast with meningeal infiltration the dorsal root ganglia may be involved ( Fig 5) .
Of the cranial nerves, infiltration of the nerves of external ocular movements in the orbit deserves mention ( Fig 6) .
Clinically cases with diffuse infiltration may present with progressive dementia, focal neurological deficit, signs of raised intracranial pressure or peripheral neuropathy. Those with a central presentation may be difficult to distinguish from progressive multifocal leuco-encephalopathy, the peripheral ones from paraneoplastic neuropathies. In the latter case involvement of cranial nerves, particularly the III, IV and VI, favours infiltration.
The diagnosis of involvement is now aided by the Cytocentrifuge (Shandon Instruments) which allows concentration of cells on a microscope slide with excellent preservation of morphology.
A new preparation of methotrexate, Methotrexate I.T., is now available for intrathecal use in the treatment of meningeal involvement by leukemia or lymphoma. It is hoped that this will lessen the side effects of the drug. Cytosine arabinoside is effective given intrathecally: it must be diluted with sterile water containing no preservative. The drugs are probably best given not in combination but as twice-weekly methotrexate for five injections followed by cytosine arabinoside at the same time intervals. Dr Arthur Jones (Department ofRadiotherapy, St Bartholomew's Hospital, London ECJ) Radiotherapy Tumours of the lymphoreticular system are as a group the most responsive of the conditions amenable to therapeutic irradiation. Judged by the rate at which a mass shrinks after exposure to a given dose of radiation, or by the ease with which a focal aggregation of cells may be sterilized, this group is of high radiosensitivity. This has two valuable consequences. First, even when the neoplastic manifestations are extensive, useful tumour regressions may be obtained with relief of symptoms. Secondly, it is becoming increasingly recognized that local cure of the disease may be obtained within a treated volume, by dosage within the tolerance of normal tissue. This important aspect has in the past been obscured by the high propensity of certain types for diffuse metastasis, and by the seemingly multicentric origin of others. In the case of Hodgkin's disease the great advances in treatment have come from differentiating histological types, from delineating distinct patterns of spread so that meaningful staging could be applied, and from recognizing that adequate radiation dosage when given to well-defined volumes of tissue which encompassed the tumour process could result in prolonged survival amounting in many cases to cure. The importance of detailed investigation, including lymphangiography and often laparotomy, now needs no emphasis (Kaplan 1972a , b, Smithers 1972 . The best treatment for Hodgkin's disease in Stages I and II without systemic symptoms has been clearly shown to be radiotherapy. This involves adequate megavoltage X-ray therapy to all the node areas on that side of the diaphragm, either by a 'mantle', or an abdominal technique such as the 'inverted Y', which spare vital organs. Dosage of 3500 to 4000 rads in 28 days is tolerated without undue constitutional or bloodcount disturbance. As 80% of patients may be expected to survive over five years, the possible effects on normal tissues are of paramount importance. In these radiotherapeutic techniques one such 'critical organ' is the spinal cord, and this is shielded posteriorly when the midline dose has reached 2000 rads. When the disease is in Stage ITTA (that is, confined to lymph nodes both above and below the diaphragm, but without systemic symptoms), the 'mantle' techique has to be followed after a month's interval by the 'inverted-Y'. The field gap has to be calculated with great accuracy to avoid an overlap at the spinal cord which could result in its receiving a total dose of over 5000 rads. The neurological significance of these points will be considered later.
In general in the treatment of lymphomata, irradiation is better for space-occupying focal lesions, while chemotherapy is better for diffuse processes. Radiotherapy is thus offirst importance in relieving pressure effects on the nervous system. Many of these are readily reversible, and the prognosis then remains that of the underlying disease which from its diffuse nature will be controllable only by chemotherapy. An important example is when the lymphoreticular disease actually presents by extradural cord compression without obvious signs of lymphnodal or visceral tumour. The diagnosis will then have been made following laminectomy, and appropriate spinal irradiation will have been started as soon as possible. It is also necessary for special investigations of the reticuloendothelial system to be started as soon as possible and concurrently with radiotherapy, as these will help in assessing the general prognosis, and in determining the need both for modifying the radiotherapeutic technique (for instance by including lymph nodes) and for the variety and timing of combination chemotherapy. A patient with 'primary' extradural lymphoma appropriately treated may well be alive in ten years if the tumour is a well-differentiated nodular lymphoma of the giant follicular or Brill-Symmers type. But if it is a poorly differentiated diffuse histiocytic lymphoma (reticulosarcoma) the outlook is dire. In Hodgkin's disease the nodular sclerotic variety which commonly causes extradural compression is compatible with survival afterwards for over five years, even with persisting evidence of disease; but in the lymphocytedepleted type the prognosis, even when focal lesions appear to be in abeyance, is distinctly poor.
It is well known that neurological involvement by the lymphomata other than leukemia is predominantly by growth in the extradural space, commonly producing cord or cauda equina compression (Williams et al. 1959) . Less often it occurs in the basicranium to give rise mainly to cranial nerve palsies and cerebellar dysfunction: on the infrequent occasions when the brain is infiltrated it is mainly from such basicranial extension, although discrete cerebral deposits have on rare occasions been recognized. Extradural involvement most often occurs in the course of established disease when the patient is being followed up in a radiotherapy department or oncological centre. As the neurological effects are most readily reversible when they are detected early, it is essential for all seeing such patients to have a 'high index of suspicion' for these complications, and to be alerted by complaints ofback pain and paresthesix before ataxia, paraparesis, or sphincter disorder dominate the picture. Myelography is essential, for plain X-rays are normal in 60 % of the cases. Because of the space available for growth a deposit in the lumbosacral canal may be large before neurological deficit ensues. But in the upper thoracic spine the converse is true and there may be considerable ataxia from a posteriorly-placed lesion before the myelogram becomes abnormal by showing a complete block. The differential diagnosis of a cord lesion in these circumstances is usually between extradural tumour compression, paraneoplastic neuromyopathy, vincristine neuropathy, and radiation myelopathy. The recognition of root pain is important, for if a patient with established vincristine neuropathy and absent reflexes becomes more ataxic, this time it may be due to extradural metastases.
The relief of extradural compression when it presents is a matter of urgency, and for most tumours emergency laminectomy is the first treatment of choice. In the lymphomata, however, a number of factors complicate the situation. While the neurological level may be well-defined, the myelogram often shows more extensive involvement and pathologically the longitudinal extent may be even greater; there may also be multiple deposits. The relief obtainable by laminectomy may therefore be very restricted, and even with departments close together neurosurgery inevitably means some delay in starting irradiation. As many of these tumours are highly radiosensitive there would, in the past, have been less hesitation in starting immediate irradiation had it not been for a lurking spectre of post-irradiational aedema. To prevent this the initial doses of irradiation were often greatly reduced and the beneficial effect restricted. These problems have been recently elucidated by experimental and clinical work carried out by Rubin in the United States (Rubin & Miller 1969 .
He injected a bolus of 5000 tumour cells of a transplantable lymphoma into the nape of the neck of a rat, where a palpable and measurable mass developed within 1-2 weeks and compressed the spinal cord by invasion of the epidural space. The severity of neurological dysfunction was measured as in clinical cases. Varying radiation dose schedules were applied, and the extent of neurological recovery measured as a function of the degree of presenting impairment and the daily dose schedule. The high daily dose schedule, that is 500 rads 3 times, gave prompt tumour regression and complete neurological recovery, while the low daily doses, 100 rads a day up to 1000 rads, showed a mixed response. These results were then applied at Rochester in a clinical series which included Hodgkin's lymphoma in adults, with in these cases 100% neurological recovery. They were also applied at Boston in a group of children's tumours ranging from Ewing's sarcoma to neuroblastoma, again with 100% neurological recovery.
Our experience at St Bartholomew s Hospital suggests that the patients likely to benefit from immediate laminectomy rather than urgent irradiation are mainly those with severe neurological deficit, often of rapid onset, when the previous history and histology suggest that the response to irradiation may be delayed. These include localized lesions of nodular sclerosing Hodgkin's disease; and some cases of diffuse histiocytic lymphoma (reticulosarcoma) in which the responses of other deposits (for instance cervical nodes) have in-that patient previously been inadequate. Corticosteroids in the form of dexamethasone often result in dramatic improvement, and radiotherapy is now always covered by this drug in sufficient dosage. An adequate length of spinal canal (often as much as 20 cm) is irradiated by a megavoltage method to a dose of 3500 rads in 20 fractions in 4 weeks; at the end of which time chemotherapy is given if blood count and bone marrow picture permit.
With improvement in the chemotherapy of acute leukemmia, particularly in childhood, the increasing incidence of meningeal leukemnia became in the early l960s a significant clinical problem. Leukemic cells gained access to the arachnoid trabecule through the walls of the veins and then the growing infiltrates ruptured the trabecule to permit escape of cells into the cerebrospinal fluid. While such cells were highly radiosensitive, and radiotherapy to the cranium or the spine produced useful symptomatic relief, the benefits were always temporary and the treatment at the most palliative.
During the last decade the approach to the treatment of acute lymphoblastic leukemia of childhood has been completely altered, thanks mainly to the work of Pinkel and his associates at St Jude Hospital at Memphis, Tennessee (Aur et a!. 1972 , Lancet 1972 . From Pinkel's systematic investigations into the feasibility of achieving cure rather than palliation, three facts stood outthe high incidence of central nervous system (CNS) involvement, over 50% in most series; that CNS leukemia usually becomes clinically apparent during systemic remission; and that systemic relapse usually follows quickly on the CNS relapse. As the total number of leukaemia cells in the CNS was likely to be at its lowest during systemic remission when they should most easily be destroyed by irradiation, Pinkel and his team set out to investigate systematically the conditions under which such sterilization could be achieved. Courses of craniospinal irradiation to total dosage of 500 rads in 13 patients and 1200 rads in 24 patients failed to prevent relapse from meningeal leukaemia in 15 out of 37 cases; but when in 1967 the total cranial radiation dosage was increased to 2400 rads in 15 fractions in 18 days and 5 doses of methotrexate were given intrathecally, only 3 out of 30 children relapsed with meningeal leukemia. Then in 1968 the effect of adding spinal irradiation (also to dosage of 2400 rads) was investigated. Only 2 out of 45 children so treated relapsed, compared with 33 out of 49 in the unirradiated group. Craniospinal irradiation was thus highly effective when given prophylactically early in the course of the disease, but it caused considerable myelosuppression which necessitated interruption of the maintenance chemotherapy. A later randomized study between cranial irradiation and methotrexate intrathecally, and craniospinal irradiation, showed the incidence of meningeal relapse to be very low in both groups, but severe neutropenia was four times higher in the group in which the spine had been -irradiated. There is thus firm evidence from Memphis that cranial irradiation combined with either spinal irradiation or intrathecal methotrexate soon after hkEmatological remission has been achieved may prevent, or at least defer, the onset of CNS leukaemia in most cases. In 1970 the Medical Research Council in this country initiated a trial in which one of the variables was prophylactic craniospinal irradiation plus intrathecal methotrexate. The spinal dose was only 1000 rads compared with Pinkel's 2400 rads. The preliminary results now reported by the Leukaemia Committee and Working Party on Leukaemia in Childhood (Medical Research Council 1973) showed that of the 80 patients who did not receive prophylactic CNS treatment remission was ended by meningeal leukemia in 26, whereas the corresponding figure for patients given prophylatic CNS treatment was only 1 out of 75. It is clear that the introduction of treatment of the central nervous system early in the disease has dramatically improved the survival of children with acute lymphoblastic leukeemia. Children who are given modern chemotherapy and CNS irradiation have more than a 50% chance of being alive and well five years later, and some are likely to be very long survivors. The neurological effects of such irradiation are therefore of considerable importance, and are considered below in relation to other known CNS effects of similar exposure.
Radiation myelopathy in its serious and progressive form occurs very rarely following radiotherapy of the reticuloses, but has to be considered in some cases of clinically progressive cord lesion. It may be seen if the cumulative cord dose has been above the well-defined limits of tolerance, due to field overlap or retreatment. After a latent period of from six months to about five years it usually shows itself as a Brown-Sequard syndrome, but the diagnosis cannot be made on neurological grounds alone. It is necessary to have full details of all the previous courses of irradiation, (not only the tumour dose but all the applied doses), the overall times of treatment, the number of fractions and the spatial distribution in that particular patient.
In contrast, the benign syndome of 'transient radiation myelopathy' is quite common and occurs in 10-20% of cases of Hodgkin's disease treated by the 'mantle' technique. Lhermitte's sign of electrical paresthesia on neck flexion is well recognized in clinical neurology as indicating an organic disorder of the cervical spinal cord. Patients in whom the cervical spine has been irradiated may develop Lhermitte's sign at periods varying from 2 to 37 weeks after the end of treatment as the sole neurological manifestation of disturbance. In two-thirds of cases the symptoms are confined to the lumbosacral segments, but in others the upper limbs or the trunk are also involved. Gradually the symptoms become less intense and frequent and they disappear completely after periods varying from 2 to 36 weeks. In no case has there been any numbness, muscle weakness, or sphincter disturbance, and no abnormal objective signs have ever appeared. The cord dose responsible has been as low as 2000 rads in 28 days. From collateral neurological evidence of similar syndromes, this condition of transient radiation myelopathy is considered to be due to temporary demyelination of sensory neurones which makes them vulnerable to slight mechanical distortion. It has been postulated that the effect depends on radiation inhibiting the activity of a proportion of the oligodendroglia along the axons of sensory neurones in the irradiated zone . The clinical latent interval corresponds with the normal survival of myelin, but when replacement is needed the turnover is defective from previous inhibition of these periaxonal satellite cells. As the oligodendroglia recovers myelin synthesis is resumed, but during the period of clinical duration of Lhermitte's sign the axons remain denuded and sensitive to physical distortion. Providing the evocative radiation dose is below the level accepted for cord tolerance none of these cases of transient radiation myelopathy progresses to later neurological sequelh. The syndrome of transient radiation myelopathy, with its short latent period and duration, does not in itself herald later cord degeneration unless the dose has been above the accepted limit, and such cases should not be included in any assessment of spinal cord tolerance to irradiation.
In 1972 a transient cerebral disturbance, manifest only by somnolence, was seen in children following cranial irradiation as part of CNS prophylaxis for acute lymphatic leukemia in remission. Freeman 
Radiotherapy
The development of a transient cerebral disturbance in which somnolence was the principal feature was recently described by my colleagues and myself in a group of children who had received cranial irradiation as part of central nervous system prophylaxis for acute lymphoblastic leuktemia in remission. The incidence of some degree of post-irradiation disturbance was almost 80% of 28 children treated identically. Half of these affected children developed a clearly defined syndrome with severe drowsiness persisting for up to seven days at the most accompanied by anorexia and irritability, and with complete recovery in all cases. A remarkably consistent latent interval of 5-6 weeks was noted in all affected cases irrespective of severity of symptoms, and the younger children tended to have the more severe symptoms.
In view of the known inhibiting effects of radiation on myelin synthesis, and the analogous syndrome of transient radiation myelopathy after cervical cord irradiation , we believe that this somnolence syndrome is a post-irradiation encephalopathy caused by a temporary inhibition of myelin synthesis. Why somnolence should be the principal clinical feature is open to speculation, but it may be relevant that the central reticular formation is one of the last areas of the mammalian brain to complete the process of myelination.
Cranial irradiation is now an important component of the total management of children with acute lymphoblastic leukeemia. We thus have a unique opportunity, and a firm clinical responsibility to study the immediate and long-term neurophysiological and neuropsychological consequences of irradiation of the immature developing human brain.
